Also trades as: LNA.PA (PAR) · $vol 0M

€25.20 ($28.16)

-3.20 (-11.27%)

Weekly Expected Move ±6.7%

€22 €24 €25 €27 €29

LSE · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 42 · €258.5M mcap · 6M float · 0.0050% daily turnover

Analysis Technicals Weather Peers

Revenue

$913M +13.1% ▲

5Y CAGR: +9.7%

Gross Profit

$102M +12.3% ▲

5Y CAGR: -26.6%

Operating Income

$75M +9.2% ▲

5Y CAGR: +15.2%

Net Income

$24M +10.7% ▲

5Y CAGR: +25.3%

EPS (Diluted)

$2.35 +10.3% ▲

5Y CAGR: +23.7%

EBITDA

$161M +10.9% ▲

5Y CAGR: +8.2%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$689M	$728M	$736M	$807M	$913M
YoY Growth	+20.1%	+5.6%	+1.1%	+9.6%	+13.1%
Cost of Revenue	$112M	$106M	$495M	$716M	$810M
Gross Profit	$578M	$622M	$241M	$91M	$102M
Gross Margin	83.8%	85.5%	32.8%	11.3%	11.2%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$82M	$87M	$90M	$553K	$333K
Operating Expenses	$519M	$559M	$178M	$193M	$27M
Operating Income	$56M	$64M	$63M	$69M	$75M
Operating Margin	8.1%	8.8%	8.6%	8.6%	8.3%
Interest Expense	$20M	$21M	$27M	$29M	$30M
Income Before Tax	$39M	$44M	$37M	$34M	$40M
Tax Expense	$15M	$16M	$13M	$11M	$14M
Net Income	$24M	$26M	$23M	$22M	$24M
Net Margin	3.4%	3.5%	3.2%	2.7%	2.6%
EPS (Diluted)	$2.45	$2.49	$2.29	$2.13	$2.35
EBITDA	$132M	$142M	$145M	$145M	$161M
Shares Outstanding	10M	10M	10M	11M	10M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$368M	$364M	$372M	$390M	$417M	$446M	$466M	$484M
Cost of Revenue	$317M	$322M	$254M	$260M	$291M	$383M	$427M	$427M
Gross Profit	$51M	$41M	$119M	$130M	$89M	$63M	$39M	$57M
Gross Margin	14.0%	11.4%	31.9%	33.3%	21.3%	14.1%	8.4%	11.7%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$16M	$3M	$35M	$46M	$778K	$18M	-$258K	$0
Operating Expenses	$32M	$18M	$87M	$97M	$97M	$36M	-$9M	$21M
Operating Income	$20M	$24M	$31M	$24M	$84M	$27M	$48M	$36M
Operating Margin	5.3%	6.5%	8.4%	6.1%	20.1%	6.0%	10.4%	7.3%
Interest Expense	$11M	$13M	$14M	$14M	$15M	$15M	$15M	$15M
Income Before Tax	$21M	$19M	$19M	$19M	$15M	$18M	$22M	$20M
Tax Expense	$8M	$6M	$7M	$6M	$5M	$6M	$8M	$7M
Net Income	$12M	$12M	$11M	$12M	$9M	$11M	$13M	$13M
Net Margin	3.3%	3.3%	3.1%	3.2%	2.3%	2.5%	2.8%	2.6%
EPS (Diluted)	$1.17	$1.16	$1.12	$1.21	$0.83	$1.10	$1.25	$1.22
EBITDA	$71M	$71M	$43M	$44M	$65M	$75M	$86M	$80M
Shares Outstanding	10M	10M	10M	10M	11M	10M	10M	10M

0OR2.L LSE